Elevated serum IL-8 levels in patients with A-T suggest that systemic inflammation may contribute to the disease phenotype.
Fifty-eight per cent of the patients with progressive disease during treatment compared with 15 % of the patients showing response to treatment (chi-squared test P (0.05) had elevated bFGF and/or VEGF serum levels.
This study assessed whether peritoneal macrophages of cirrhotic patients can be up-regulated to produce VEGF under proper stimulatory conditions.
VEGF-A also up-regulated VEGFR-2 and phosphorylated CREB , and protected H19-7 neurons and b. End3 endothelial cells against OGD.